{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:21:01Z","timestamp":1766269261937},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T00:00:00Z","timestamp":1414022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12098-014-1606-1","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T05:08:39Z","timestamp":1413954519000},"page":"458-461","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Low-dose Rasburicase in Hematologic Malignancies"],"prefix":"10.1007","volume":"82","author":[{"given":"Somasundaram","family":"Jayabose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vignesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeswari","family":"Dhanabalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnakumar","family":"Rathnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Kasi","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,23]]},"reference":[{"key":"1606_CR1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00860936","volume":"9","author":"SL Saccente","year":"1995","unstructured":"Saccente SL, Kohaut EC, Berkow RL. Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration. Pediatr Nephrol. 1995;9:569\u201373.","journal-title":"Pediatr Nephrol"},{"key":"1606_CR2","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","volume":"364","author":"SC Howard","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364:1844\u201354.","journal-title":"N Engl J Med"},{"key":"1606_CR3","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2215\/CJN.03150312","volume":"7","author":"FP Wilson","year":"2012","unstructured":"Wilson FP, Berns JS. Onco-nephrology: tumor lysis synbdrome. Clin J Am Soc Nephrol. 2012;7:1730\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1606_CR4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1200\/JCO.2001.19.3.697","volume":"19","author":"CH Pui","year":"2001","unstructured":"Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverer G, Camita B, et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol. 2001;19:697\u2013704.","journal-title":"J Clin Oncol"},{"key":"1606_CR5","first-page":"275","volume":"18","author":"S Ueng","year":"2005","unstructured":"Ueng S. Rasburicase (Elitek): a novel agent for tumor lysis syndrome. BUMC Proc. 2005;18:275\u20139.","journal-title":"BUMC Proc"},{"key":"1606_CR6","unstructured":"Diwedi P, Bhosle B, Chinnaswamy G, Aurora B, Banavali SD. Single dose\/single vial rasburicase in the management of pediatric patients with hyperuricemia\/tumor lysis syndrome. Pediatr Blood Cancer. 2013. ASPHO abstracts. Poster 766"},{"key":"1606_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS, Bishop M. Tumor lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127:3\u201311.","journal-title":"Br J Haematol"},{"key":"1606_CR8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/annonc\/mdf134","volume":"13","author":"C Patte","year":"2002","unstructured":"Patte C, Sakiroglu O, Ansoborlo S, Baruchel A, Plouvier E, Pacquement H, et al. Urate oxidase in the prevention and treatment of metabolic complications in patients with lymphoma and leukemia treated in the Societe Francaise d\u2019 oncolgie Pediatric LMB 89 protocol. Ann Oncol. 2002;13:789\u201395.","journal-title":"Ann Oncol"},{"key":"1606_CR9","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/bjc.1998.379","volume":"77","author":"A Atra","year":"1998","unstructured":"Atra A, Gerrard M, Hobson R, Imeson JD, Ashley S, Pinkerton CR. Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin\u2019s lymphoma (B-NHL)\u2013 results of the UKCCSG 9003 protocol. Br J Cancer. 1998;77:2281\u20135.","journal-title":"Br J Cancer"},{"key":"1606_CR10","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.1996.14.4.1252","volume":"14","author":"WP Bowman","year":"1996","unstructured":"Bowman WP, Shuster JJ, Cook B, Griffin T, Behm F, Pullen J, et al. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. J Clin Oncol. 1996;14:1252\u201361.","journal-title":"J Clin Oncol"},{"key":"1606_CR11","doi-asserted-by":"crossref","unstructured":"Cheuk DKL, Chiang AKS, Chan GCF, Ha SY. Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer. Cochrane Database Syst Rev. 2010;6: CD006945","DOI":"10.1002\/14651858.CD006945.pub2"},{"key":"1606_CR12","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/annonc\/mdr490","volume":"23","author":"S Vadhan-Raj","year":"2012","unstructured":"Vadhan-Raj S, Fayad LE, Fanale MA, Pro B, Rodriquez A, Hagemeister FB, et al. A randomized triali of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome. Ann Oncol. 2012;23:1640\u20135.","journal-title":"Ann Oncol"},{"key":"1606_CR13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/phar.1198","volume":"33","author":"A McBride","year":"2013","unstructured":"McBride A, Lathon SC, Boehmer L, Augustin KM, Butler, Westervelt P. Comparative evaluation of single fixed dosing and weight based dosing of rasburicase for tumor lysis syndrome. Pharmacotherapy. 2013;33:295\u2013303.","journal-title":"Pharmacotherapy"},{"key":"1606_CR14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jcpt.12061","volume":"38","author":"X Feng","year":"2013","unstructured":"Feng X, Dong K, Pence S, Inciardi J, Bhutada NS. Efficacy and cost of single dose rasburicase in prevention and treatment of adult tumor lysis syndrome: a meta-analysis. J Clin Pharm Ther. 2013;38:301\u20138.","journal-title":"J Clin Pharm Ther"},{"key":"1606_CR15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/cncr.11612","volume":"98","author":"A Bosley","year":"2003","unstructured":"Bosley A, Sonet A, Pinkerton CR, McCowage G, Bron D, Sanz MA, et al. Rasburicase (recombinant urate oxidase) for management of hyperuricemia in patients with cancer. Cancer. 2003;98:1048\u201354.","journal-title":"Cancer"},{"key":"1606_CR16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12098-013-1187-4","volume":"81","author":"S Bakhshi","year":"2014","unstructured":"Bakhshi S, Bikramjit Singh R, Munot K, Pathania S. Complications of \u201cvery high\u201d leukocytosis in pediatric acute leukemia patients managed without rasburicase or leukopheresis. Indian J Pediatr. 2014;81:817\u201320.","journal-title":"Indian J Pediatr"},{"key":"1606_CR17","doi-asserted-by":"crossref","unstructured":"Allen KC, Champlain AH, Cotliar J, Belknap SM, West DP, Mehta J, et al. Anaphylaxis associated with administration of repeated courses of rasburicase: a research on adverse drug events and reports (RADAR) Project. Am Soc Hematol. Annual meeting 2012. Abstract# 1351.","DOI":"10.1182\/blood.V120.21.1351.1351"},{"key":"1606_CR18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000351048","volume":"130","author":"CY Cheah","year":"2013","unstructured":"Cheah CY, Lew TA, Seymour JF, Burbury K. Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6 phosphate dehydrogenase deficiency. Acta Haematol. 2013;130:254\u20139.","journal-title":"Acta Haematol"},{"key":"1606_CR19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.23182","volume":"88","author":"MB Sonbol","year":"2013","unstructured":"Sonbol MB, Yadav H, Vaidya R, Rana V, Witzig TE. Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase. Am J Hematol. 2013;88:152\u20134.","journal-title":"Am J Hematol"},{"key":"1606_CR20","first-page":"1045","volume":"46","author":"H Nair","year":"2009","unstructured":"Nair H. Neonatal screening program for G6PD deficiency in India: need and feasibility. Indian Pediatr. 2009;46:1045\u20139.","journal-title":"Indian Pediatr"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-014-1606-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-014-1606-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-014-1606-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T01:41:31Z","timestamp":1598406091000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-014-1606-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,23]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1606"],"URL":"https:\/\/doi.org\/10.1007\/s12098-014-1606-1","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,23]]}}}